The German regulatory authority has given approval to Dr Reddy’s, Visakhapatnam based plant to restart production for the European market (EU). In a regulatory filing the...
Dr.Reddy’s Laboratories has received an establishment inspection report (EIR), for its formulation manufacturing facility at Duvvada in Visakhapatnam, from the US health regulator. The company has...
Dr Reddy’s Laboratories has obtained establishment inspection report(EIR) for a unit of its  Srikakulam plant in Andhra Pradesh, from the US health regulator. In a filing...
Dr Reddy’s Laboratories (DRL) has launched Bivalirudin injection which is indicated for use as an anti-coagulant in patients, after getting approval from the US health...
On Thursday, Dr Reddy’s Laboratories has announced the launch of tablets of cholesterol lowering generic combination drugs Ezetimibe and Simvastatin in the US. The company...
Dr Reddy’s has launched generic Progesterone capsules that are used in the treatment of menstrual irregularities and protection of the lining of uterus in the...
The USFDA has completed the inspection of Dr. Reddy’s facilities in Srikakulam, Andhra Pradesh without making any observations. The USFDA audit has been conducted at...
Dr Reddy’s Laboratories has got 13 observations from the US health regulator for its formulation manufacturing facility at Duwada, Vishakhapatnam. Dr Redd’s Laboratories has said...
Dr Reddy’s Laboratories has launched Bupropion extended release tablets, an anti-depressant in the US market. Dr Reddy’s Laboratories has said in a regulatory filing that...